WebGelesis is a biotechnology company located in Boston, Massachusetts that developed the weight loss device Gelesis100 (Plenity) for use in overweight and obesity. The company … WebJul 19, 2024 · Gelesis and Capstar will host a joint investor conference call to discuss the transaction today, July 19, 2024, at 8:30 a.m. Eastern Time. A telephone replay of the …
Gelesis Holdings, Inc. (GLSH) SEC Filings Nasdaq
WebAug 23, 2024 · Investor Presentation Virgin Orbit Home Vision Launch The Virgin Way Missions Investor Information Careers Orbit for Everyone Team Contact Us The Latest … WebInvestors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ... henry 430
Gelesis to Report Full Year 2024 Financial Results on March 24, 2024
WebMar 28, 2024 · A pre-recorded webcast discussing these results is available on the “Events & Presentations” section of the Gelesis Investor Relations website at … WebGelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease ... WebAug 15, 2024 · Gelesis management will host a conference call today at 8:30 am ET to discuss the second quarter 2024 results, followed by a question-and-answer period. The … henry 422 fortify